Markus Puhlmann, Chief Medical Officer at Perspective Therapeutics, Inc. (CATX), bought 280,000 shares at $0.50 ($140K) on 2024-01-24, disclosed to the SEC on 2024-01-26.
Open-market purchase of $140k CATX by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.